Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1H&P----[1] 226 💬
2H-116PI-DE.pdf----[1] 18 💬
3H-ATG (ATGAM )----[1] 60 💬
4H. pylori triple therapy----[1] 63 💬
5H.P. Acthar Gel----[5] 46, 49, 50, 84, 222 💬
6H.P. Acthar Gel (repository corticotropin injection)[1] Corticotropin[2] Corticotropin ,
Corticotropin, repository 💬 		[1] MC2R 💬 [6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 13 💬
7H.P. Acthar® Gel----[1] 14 💬
8H01BB02----[1] 193 💬
9H01C B03----[1] 77 💬
10H02 - Corticosteroidi Sistemici----[1] 299 💬
11H021----[1] 97 💬
12H02AB----[1] 97 💬
13H02AB02----[1] 28 💬
14H02AB02 Desametasone----[1] 28 💬
15H02AB04----[1] 46 💬
16H02AB07----[1] 46 💬
17H02AB09----[1] 41 💬
18H05AA02----[1] 274 💬
19H1 Blocker----[1] 257 💬
20H2 Blocker----[1] 257 💬
21H44AON188----[1] 113 💬
22H51AON23----[1] 113 💬
23H5G1.1-mAb----[3] 13, 50, 62 💬
24HA 1A ANTICORPO MONOCLONALE UMANO CLASSE IGM----[2] 6, 49 💬
25HA20 (IMMU-106)----[1] 46 💬
26Habitrol----[1] 84 💬
27Haemoblock----[2] 157, 280 💬
28Haemocomplettan P----[1] 65 💬
29Haemocomplettan(R) P----[1] 65 💬
30Haemocomplettan(R) P 1g/2g----[1] 65 💬
31HAEMOPHILUS INFLUENZAE----[5] 61, 62, 63, 66, 223 💬
32HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE)----[2] 13, 14 💬
33Haemophilus type b vaccine (conjugated)----[1] 14 💬
34Haemostasis tests----[1] 113 💬
35HAESCs----[1] 6 💬
36HAESCs treatment----[1] 6 💬
37Halometasone[1] Halometasone[1] Halometasone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 162 💬
38Haloperidol[1] Haloperidol[3] Haloperidol ,
Haloperidol decanoate ,
Haloperidol lactate 💬 		[1] DRD2 💬 [10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 8 💬
39Haloperidol 2Mg Tab[1] Haloperidol[3] Haloperidol ,
Haloperidol decanoate ,
Haloperidol lactate 💬 		[1] DRD2 💬 [10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 8 💬
40Haplo HSCT----[1] 60 💬
41Haplo/cord transplant----[1] 60 💬
42Haploidentical donor bone marrow transplant----[1] 60 💬
43Haploidentical Hematopoietic Cell Transplantation----[2] 60, 65 💬
44Haploidentical hematopoietic cell transplantation combined with unrelated cord blood stem cells----[1] 60 💬
45Haploidentical HSCT using TBI free regimen, ''ATG'' with ''Post transplant cyclophosphamide''[1] Cyclophosphamide[2] Cyclophosphamide ,
Cyclophosphamide 💬 		--[1] 60 💬
46Harmonized supportive care----[2] 38, 39 💬
47HATG----[1] 60 💬
48Havrix----[1] 46 💬
49HB- adMSCs (Hope Biosciences adipose derived mesenchymal stem cells)----[1] 6 💬
50HB-adMSCs----[8] 2, 4, 6, 13, 14, 46, 49, 113 💬
51HB-adMSCs - Hope Biosciences Adipose Derived Mesenchymal Stem Cells----[2] 17, 96 💬
52HB0034----[1] 37 💬
53HB2198----[1] 49 💬
54HBI-002----[1] 6 💬
55HBI0101 CART----[5] 11, 13, 46, 49, 51 💬
56HBM7020----[3] 46, 49, 51 💬
57HBM9161----[1] 14 💬
58HBM9161 Dose A----[1] 63 💬
59HBM9161 Dose B----[1] 63 💬
60HBM9161 Injection----[1] 13 💬
61HBM9161 Injection (340 mg)----[1] 11 💬
62HBM9161 Injection (680mg and 340 mg)----[1] 11 💬
63HBM9161 Injection (680mg)----[1] 11 💬
64HBVAXPRO----[2] 46, 50 💬
65HBVAXPRO 5 micrograms/0.5 ml----[1] 46 💬
66HBVAXPRO 5 micrograms/0.5 ml Suspension for injection Hepatitis B vaccine (rDNA)----[1] 46 💬
67HBVAXPRO® 40 micrograms----[1] 46 💬
68HC-58----[1] 149 💬
69HC022----[1] 49 💬
70HCQ----[2] 46, 49 💬
71HCQ/CQ and CAB combined treatment----[1] 74 💬
72HCT----[1] 67 💬
73HD-DXM----[1] 63 💬
74HD-TIV----[1] 46 💬
75HE3286----[2] 46, 97 💬
76Healthy donor-derived FMT capsule----[1] 6 💬
77HEC 68498----[1] 85 💬
78HEC122505MsOH----[1] 6 💬
79HEC585----[1] 85 💬
80Helicobacter pylori eradication therapy----[1] 6 💬
81Helium[1] Helium[1] Helium 💬 --[3] 228, 299, 330 💬
82Helminth ova----[1] 13 💬
83Helopanflat Mono®----[1] 298 💬
84Hematide, peginesatide[1] Peginesatide[2] Peginesatide ,
Peginesatide acetate 💬 		[1] EPOR 💬 [7] Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬[1] 283 💬
85Hematopoetic stem cell infusion----[1] 13 💬
86Hematopoetic Stem Cell Transplantation----[6] 19, 65, 121, 160, 308, 326 💬
87Hematopoietic bone marrow transplantation----[1] 36 💬
88Hematopoietic Cell Transplantation----[2] 49, 60 💬
89Hematopoietic stem cell infusion----[2] 19, 20 💬
90Hematopoietic Stem Cell Therapy----[1] 13 💬
91Hematopoietic Stem Cell Transplant----[2] 65, 285 💬
92Hematopoietic stem cell transplant (HSCT)----[1] 65 💬
93Hematopoietic Stem Cell Transplantation----[13] 11, 13, 14, 19, 20, 35, 46, 49, 51, 65, 96, 234, 285 💬
94Hematopoietic stem cell transplantation (HSCT)----[2] 13, 60 💬
95Hemay005----[2] 56, 271 💬
96Hemay005 tablet----[1] 97 💬
97Hemay005 tablets----[1] 97 💬
98Hemay007----[1] 97 💬
99Hemay007 1200 mg QD group----[1] 46 💬
100Hemay007 600 mg QD group----[1] 46 💬
101Hemay007 800 mg QD group----[1] 46 💬
102Heme arginate[1] Heme arginate---[1] 254 💬
103Hemin[1] Hemin[1] Hemin 💬 [2] ALAS1,
ALAS2 💬 		[2] Glycine, serine and threonine metabolism, Porphyrin metabolism 💬[1] 254 💬
104Hemin for injection[1] Hemin[1] Hemin 💬 [2] ALAS1,
ALAS2 💬 		[2] Glycine, serine and threonine metabolism, Porphyrin metabolism 💬[1] 254 💬
105Hemlibra®----[1] 288 💬
106Hemoglobin[1] Hemoglobin---[3] 6, 60, 283 💬
107Henagliflozin[1] Henagliflozin---[3] 58, 66, 218 💬
108Henagliflozin (SGLT2 Inhibitor)[1] Henagliflozin---[1] 58 💬
109Heparesc----[1] 251 💬
110Heparin[1] Heparin[2] Heparin sodium ,
Heparin calcium 💬 		[1] SERPINC1 💬 [1] Complement and coagulation cascades 💬[15] 47, 48, 60, 65, 70, 79, 84, 107, 224, 226, 280, 299, 316, 317, 344 💬
111Heparin & Alkalinized Lidocaine Bladder Instillation[2] Heparin,
Lidocaine		[5] Lidocaine ,
Lidocaine hydrochloride ,
Heparin sodium ,
Heparin calcium ,
Lidocaine hydrochloride monohydrate 💬 		[7] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A,
SERPINC1 💬 		[6] Adrenergic signaling in cardiomyocytes, Cadherin signaling, Complement and coagulation cascades, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬[1] 226 💬
112Heparin 25mg inhalation powder, hard capsule[1] Heparin[2] Heparin sodium ,
Heparin calcium 💬 		[1] SERPINC1 💬 [1] Complement and coagulation cascades 💬[1] 299 💬
113Heparin calcium5,000 U twice daily plus low dose aspirin[1] Heparin[2] Heparin sodium ,
Heparin calcium 💬 		[1] SERPINC1 💬 [1] Complement and coagulation cascades 💬[1] 48 💬
114Heparin Sodium[1] Heparin[2] Heparin sodium ,
Heparin calcium 💬 		[1] SERPINC1 💬 [1] Complement and coagulation cascades 💬[2] 280, 299 💬
115Heparin-induced extracorporeal LDL precipitation[1] Heparin[2] Heparin sodium ,
Heparin calcium 💬 		[1] SERPINC1 💬 [1] Complement and coagulation cascades 💬[1] 79 💬
116Heparán N sulfatasa humana recombinante----[1] 19 💬
117Heparán N sulfatasa humana recombinante (rhHNS)----[1] 19 💬
118HepaStem----[1] 251 💬
119HepaStem Infusion----[1] 251 💬
120Hepatitis A Vaccine[1] Hepatitis A Vaccine---[3] 46, 96, 97 💬
121Hepatitis A vaccine ( HAVRIX or EPAXAL)[1] Hepatitis A Vaccine---[1] 46 💬
122Hepatitis A vaccine and tetanus vaccine[1] Hepatitis A Vaccine---[1] 46 💬
123Hepatitis B vaccine----[1] 97 💬
124HEPATITIS B VACCINE (RDNA)----[1] 46 💬
125HEPATITIS B VIRUS SURFACE ANTIGEN RECOMBINANT (S PROTEIN)----[1] 46 💬
126Hepatocyte Transplant----[1] 240 💬
127Heptaminol[1] Heptaminol[2] Heptaminol ,
Heptaminol hydrochloride 💬 		--[1] 6 💬
128Heptaminol hydrochloride[1] Heptaminol[2] Heptaminol ,
Heptaminol hydrochloride 💬 		--[1] 6 💬
129HER-096----[1] 6 💬
130Heracillin----[1] 299 💬
131Herbal Medicinal Mixture (Roucongrong, Heshouwu etc.)----[1] 6 💬
132Herbal medicine----[1] 70 💬
133Herbal treatment (SA100)----[1] 97 💬
134Hericium erinaceus mycelium----[1] 6 💬
135Herombopag----[2] 60, 63 💬
136Herombopag + CsA----[1] 60 💬
137Herombopag olamine tablets----[1] 63 💬
138Herpes Zoster Subunit (HZ/su) Vaccine----[1] 49 💬
139Herpes Zoster Vaccine----[3] 46, 96, 271 💬
140HESC-RPE----[1] 301 💬
141Hesperidin[1] Hesperidin[1] Hesperidin 💬 --[3] 13, 46, 93 💬
142Heterologous booster----[1] 13 💬
143Heterologous Human Adult Liver-derived Progenitor Cells----[1] 251 💬
144Heterologous Human Adult Liver-derived Progenitor Cells (HHALPC)----[1] 251 💬
145Hetrombopag[1] Hetrombopag---[2] 60, 63 💬
146Hetrombopag 5mg po qd[1] Hetrombopag---[1] 63 💬
147Hetrombopag Olamine[1] Hetrombopag---[2] 60, 63 💬
148Hetrombopag Olamine Tablet[1] Hetrombopag---[1] 60 💬
149Hetrombopag Olamine+Standard Therapy[1] Hetrombopag---[1] 60 💬
150Hextend----[2] 96, 97 💬
151HF0220----[1] 6 💬
152HF2----[1] 97 💬
153HFNT during exercise----[1] 299 💬
154Hgd40----[1] 97 💬
155HGP1206----[1] 86 💬
156HGPIV diagnosis test----[1] 299 💬
157HGS1006----[1] 49 💬
158HGS1006, LymphoStat-B----[1] 53 💬
159HGS1006, LymphoStat-B, monoclonal anti-BLyS, LSB, BENLYSTA----[2] 49, 53 💬
160HGS1025----[1] 97 💬
161HGT-1110----[1] 19 💬
162HGT-1111----[1] 19 💬
163HGT-1410----[1] 19 💬
164HGT-2310----[1] 19 💬
165HHALPC----[1] 251 💬
166HHLivC----[1] 251 💬
167Hiberix----[1] 13 💬
168HIBERIX - POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE PER USO INTRAMUSCOLARE 1 FLACONCINO DI POLVERE + 1 SIRINGA PRERIEMPITA DI SOLVENTE DA 0.5 ML----[5] 61, 62, 63, 66, 223 💬
169HIDONAC*EV 1FL 5G 25ML----[1] 51 💬
170Hidrocloruro de efedrina[1] Ephedrine[3] Ephedrine ,
Ephedrine hydrochloride ,
Ephedrine sulfate 💬 		[9] ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬 		[16] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 11 💬
171Hidrocloruro de fingolimod[1] Fingolimod[3] Fingolimod hydrochloride ,
Fingolimod ,
Fingolimod lauryl sulfate 💬 		[1] S1PR1 💬 [4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[2] 13, 14 💬
172HIDROFEROL----[1] 113 💬
173Hidroferol®----[1] 113 💬
174HIDS DONOR----[1] 19 💬
175High cheese intake.----[1] 238 💬
176High Cut-off Hemodialysis----[1] 28 💬
177High Density Surface Electromyographic, precision botulinum neurotoxin injection guidance medical device----[1] 226 💬
178High Dietary Sodium----[1] 49 💬
179High dose----[1] 97 💬
180High dose AFFITOPE® PD03A + Adjuvant----[1] 6 💬
181High dose ANAVEX2-73----[1] 6 💬
182High Dose Aspirin (1300 mg/day)----[1] 13 💬
183High dose BIBF 1120 twice daily----[1] 85 💬
184High Dose Budesonide[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
185High dose budesonide rectal foam[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
186High dose budesonide suspension[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
187High dose budesonide tablet[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
188High dose dexamethasone[1] Dexamethasone[3] Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 63 💬
189High dose Dexamethasone pulses[1] Dexamethasone[3] Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 63 💬
190High dose GR1603 in phase ?----[1] 49 💬
191High dose GR1603 in phase?b----[1] 49 💬
192High Dose GT-02287----[1] 6 💬
193High dose influenza vaccine (HDIV)----[1] 97 💬
194High dose lactulose[1] Lactulose[1] Lactulose 💬 --[1] 291 💬
195High dose levodopa[1] Levodopa[1] Levodopa 💬 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		[13] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
196High Dose Mesenchymal Stem Cells (MSCs)----[1] 49 💬
197High Dose MT-1303----[1] 97 💬
198High Dose MYOBLOC (20,000 Units)----[1] 13 💬
199High dose of BIIL 284 BS tablets----[1] 46 💬
200High dose of budesonide[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 299 💬
201High dose of MRM-3379----[1] 206 💬
202High dose ORTD-1----[1] 46 💬
203High dose TSO----[1] 96 💬
204High dose vehicle control----[1] 46 💬
205High Dose-VIS649----[1] 66 💬
206High doses of Thiamine y Biotin[2] Biotin,
Thiamine		[4] Biotin ,
Thiamine hydrochloride ,
Thiamine mononitrate ,
Thiamine 💬 		--[1] 8 💬
207High Fiber supplement----[1] 6 💬
208High frequency ultrasonography----[1] 46 💬
209High gluten diet----[1] 97 💬
210High MCT formula----[1] 296 💬
211High milk intake.----[1] 238 💬
212High Oligosaccharide Group----[1] 96 💬
213High Phenolic Extra Virgin Olive Oil[1] Olive oil[1] Olive oil 💬 --[1] 13 💬
214High Protein and Low Fiber Diet----[1] 97 💬
215High protein high fiber diet----[2] 93, 95 💬
216High Protein. T-Diet plus Range----[1] 6 💬
217High serine diet[1] Serine[1] Serine 💬 --[1] 96 💬
218High water intake[1] Water[1] Water 💬 --[1] 67 💬
219High-caloric fatty diet----[1] 2 💬
220High-carbohdyrate breakfast----[1] 265 💬
221High-Ceiling Diuretics----[1] 57 💬
222High-dose calcium (400 mg x 4), vitamin D (19 mikg x 4), and active vitamin D supplementation (2 mikg x 2)[2] Calcium,
Vitamin D		---[1] 235 💬
223High-Dose CICR-NAM----[1] 97 💬
224High-dose corticosteroid pulse therapy----[1] 13 💬
225High-dose Cyclophosphamide[1] Cyclophosphamide[2] Cyclophosphamide ,
Cyclophosphamide 💬 		--[1] 96 💬
226High-dose Dexamethasone[1] Dexamethasone[3] Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 63 💬
227High-Dose Dexamethasone Combined[1] Dexamethasone[3] Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 63 💬
228High-Dose Dexamethasone Combined with Orelabrutinib[2] Dexamethasone,
Orelabrutinib		[4] Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate ,
Orelabrutinib 💬 		[2] BTK,
NR3C1 💬 		[8] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[1] 63 💬
229High-dose intravenous immunoglobulin (IVIG)----[1] 18 💬
230High-dose intravenous immunoglobulin (Venoglobulin-IH)----[1] 51 💬
231High-dose intravenous methylprednisolone[1] Methylprednisolone[2] Methylprednisolone ,
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
232High-dose MH002----[1] 97 💬
233High-dose REGN4461----[1] 265 💬
234High-dose vitamin D (2000 IU per day)[1] Vitamin D---[1] 274 💬
235High-Dose Vitamin D3----[1] 299 💬
236High-Frequency-Only Stimulation----[1] 6 💬
237High-Intensity Focused Electromagnetic Therapy----[1] 13 💬
238High-intensity lipid-lowering therapy----[2] 46, 49 💬
239High-resolution peripheral quantitative computed tomography (HR-pQCT)----[1] 46 💬
240High/Low Sodium Diet----[1] 13 💬
241Higher Dose of Rituximab[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 63 💬
242Higher-volume C1-esterase inhibitor----[1] 65 💬
243Himan Normal Immunoglobulin----[1] 14 💬
244Hiomega-3 supplement of Naturalis® company -----[1] 49 💬
245HiPSC-CM therapy----[1] 57 💬
246HiSCs----[1] 46 💬
247Histamine[1] Histamine[3] Histamine dihydrochloride ,
Histamine phosphate ,
Histamine 💬 		[4] HRH1,
HRH2,
HRH3,
HRH4 💬 		[5] Calcium signaling pathway, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[1] 13 💬
248Histidine[1] Histidine[1] Histidine 💬 --[3] 13, 169, 170 💬
249Histone Deacetylase Inhibitor----[1] 127 💬
250History and physical----[1] 231 💬
251History and physical exam.----[2] 231, 299 💬
252Histrelin[1] Histrelin[2] Histrelin acetate ,
Histrelin 💬 		[1] GNRHR 💬 [3] GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬[1] 76 💬
253Histrelin Subcutaneous Implant[1] Histrelin[2] Histrelin acetate ,
Histrelin 💬 		[1] GNRHR 💬 [3] GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬[1] 76 💬
254HIV Anti-retroviral Background Therapy----[1] 265 💬
255Hizentra----[4] 14, 50, 51, 65 💬
256HIZENTRA ®----[1] 11 💬
257Hizentra®----[2] 14, 65 💬
258HK-001----[1] 2 💬
259HK-660S----[1] 94 💬
260HK-660S 100mg----[1] 94 💬
261HK-660S 200mg----[1] 94 💬
262HL-085----[1] 34 💬
263HL-400----[1] 6 💬
264HL161BKN----[1] 14 💬
265HL237----[1] 46 💬
266HL237 tablet----[1] 46 💬
267HLA-identical allogeneic mesoangioblasts----[1] 113 💬
268HLB-001----[1] 246 💬
269HLL2----[1] 49 💬
270HLL2 (Epratuzumab)[1] Epratuzumab[1] Epratuzumab 💬 [1] CD22 💬 [3] B cell receptor signaling pathway, Cell adhesion molecule (CAM) interaction, Hematopoietic cell lineage 💬[1] 49 💬
271HLL2 (trivial name or chemical description)----[1] 49 💬
272HLL2,IMMU-103----[1] 49 💬
273HLX-1502----[1] 34 💬
274HLX01----[1] 46 💬
275HM15421/GC1134A----[1] 19 💬
276HM201----[2] 96, 97 💬
277HM71224 food effect----[1] 46 💬
278HM71224 Multiple ascending dose----[1] 46 💬
279HM71224 single ascending dose----[1] 46 💬
280HMABs----[1] 113 💬
281HMB----[1] 96 💬
282HMED-IdeS----[2] 64, 221 💬
283HMG Coenzyme reductase----[1] 79 💬
284HMG-Coenzyme inhibitor (statin)----[1] 218 💬
285HMI-103[1] HMI-103---[1] 240 💬
286HMI-203[1] HMI-203---[1] 19 💬
287HMPL-004----[2] 96, 97 💬
288HMPL-004 1800 mg/day----[1] 97 💬
289HMPL-004 2400 mg/day----[1] 97 💬
290HMPL-004 high dose----[1] 97 💬
291HMPL-004 low dose----[1] 97 💬
292HMPL-523----[2] 46, 63 💬
293HMPL-523(300mg PO QD)----[1] 61 💬
294HMPL004-6599----[2] 96, 97 💬
295HMR 1726D----[1] 13 💬
296HMR1726----[1] 13 💬
297HMR1726D----[1] 13 💬
298HMSCs----[1] 299 💬
299HN2301 injection----[4] 11, 46, 49, 51 💬
300HN2302 Injection----[3] 11, 49, 51 💬
301HNC364----[1] 6 💬
302HNC364 Injectable Suspension----[1] 6 💬
303HNSC----[1] 2 💬
304HNSC-01----[1] 8 💬
305Hologene 5----[1] 36 💬
306Hologene 5Pharmaceutical Form: Living tissue equivalentINN or Proposed INN: Not Yet AssignedCAS Number: Not AppCurrent Sponsor code: Hologene 5 DSOther descriptive name: Ex-vivo-expanded autologous human keratinocytes containing epidermal stem cells transduced with a LAMB3-encoding retroviral vectorConcentration unit: U unit(s)Concentration type: rangeConcentration number: 20000000-30000000----[1] 36 💬
307HOLOGENE17----[1] 36 💬
308HOLOGENE7----[1] 36 💬
309HOMAR-IR diagnosis test----[1] 299 💬
310Home based balance training----[2] 6, 13 💬
311Home Oral Glucose Tolerance Test kit----[1] 299 💬
312Homeostasis Model Assessment of insulin resistance (HOMA)----[1] 17 💬
313Homocysteine[1] Homocysteine---[1] 229 💬
314Homologous booster----[1] 13 💬
315HOMSC300----[1] 17 💬
316Honey[1] Honey[1] Honey 💬 --[4] 57, 63, 98, 230 💬
317Hookworm larvae----[1] 13 💬
318HORA-PDE6B (AAV2/5.hPDE6B)----[1] 90 💬
319Hormonal balance measurements----[1] 81 💬
320Hormonal profile----[1] 113 💬
321Hormone (prednisone)[1] Prednisone[1] Prednisone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 66 💬
322Horse Anti-thymocyte Globulin----[2] 285, 326 💬
323Horse anti-thymocyte globulin (ATG)----[1] 60 💬
324Horse anti-thymocyte globulin (hATG)----[1] 60 💬
325Horse chestnut[1] Horse chestnut[1] Horse chestnut 💬 --[1] 210 💬
326Horse-Anti-thymocyte-Globulin----[1] 60 💬
327Hospital-Based Vaccination Pathway----[1] 97 💬
328Hourly dosing of the nychtemeral secretion of melatonin[1] Melatonin[1] Melatonin 💬 [2] MTNR1A,
MTNR1B 💬 		[2] Circadian entrainment, Neuroactive ligand-receptor interaction 💬[1] 202 💬
329HOV-12020[1] HOV-12020---[2] 6, 124 💬
330HOV-12020 (Palm tocotrienols complex)[1] HOV-12020---[1] 124 💬
331HP 129Xe----[1] 299 💬
332Hp 129Xenon----[1] 228 💬
333HP 13C pyruvate injection----[1] 13 💬
334HP 3He----[1] 299 💬
335HP184----[1] 13 💬
336HP802-247----[1] 36 💬
337HPC cell infusion----[1] 45 💬
338HPC, A Infusion----[1] 60 💬
339HPN-100----[1] 251 💬
340HPV prophylactic vaccine Gardasil----[1] 49 💬
341HR19042 capsule----[1] 66 💬
342HR19042 Capsule, Tarpeyo®, Budenofalk®----[2] 66, 95 💬
343HR19042 Capsules----[2] 66, 95 💬
344HRA052015----[1] 75 💬
345HRA052015 (mifepristone)[1] Mifepristone[1] Mifepristone 💬 [2] NR3C1,
PGR 💬 		[6] Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Neuroactive ligand-receptor interaction, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬[1] 75 💬
346HRG2010----[1] 6 💬
347HRG2010 Capsule, Sinemet®, Madopar®----[1] 6 💬
348HRG2010(I)----[1] 6 💬
349HRG2010(II)----[1] 6 💬
350HrIL-2 active----[3] 46, 49, 53 💬
351HRPC----[1] 90 💬
352HRPC DP----[1] 90 💬
353HRS-1893----[1] 58 💬
354HRS-1893 Tablet----[1] 58 💬
355HRS-1893 Tablets----[1] 58 💬
356HRS-5965----[2] 66, 223 💬
357HRS-5965 capsule----[1] 62 💬
358HRS-5965 Capsules----[2] 62, 66 💬
359HRS-5965 tablets----[2] 62, 66 💬
360HRS-7085----[1] 97 💬
361HRS-7085 tablets----[1] 97 💬
362HRS-9813----[1] 85 💬
363HS-10390----[1] 66 💬
364HS-10390 tablet----[2] 66, 222 💬
365HS-10511 Tablets----[1] 58 💬
366HS-10542----[1] 62 💬
367HS-10542 High Dose----[1] 66 💬
368HS-10542 Low Dose----[1] 66 💬
369HS135----[1] 86 💬
370HS235----[1] 86 💬
371HS628+MTX----[1] 46 💬
372HS_SW01 cells injection----[2] 51, 271 💬
373HSK31858----[1] 299 💬
374HSK31858, tablet----[1] 299 💬
375HSK39297----[2] 62, 66 💬
376HSK39297 100mgBID----[1] 66 💬
377HSK39297 200mgQD----[1] 66 💬
378HSK39297 300mgQD----[1] 66 💬
379HSK39297 50mgBID----[1] 66 💬
380HSK39297 tablets----[1] 62 💬
381HSK44459----[1] 85 💬
382HSK44459 dose 1----[1] 85 💬
383HSK44459 dose 2----[1] 85 💬
384HSK44459 dose 3----[1] 85 💬
385HSK47388----[1] 97 💬
386HST5040----[2] 245, 246 💬
387HT-100----[1] 113 💬
388HTD1801----[1] 94 💬
389HTEA----[1] 57 💬
390HTK cardioplegia----[1] 215 💬
391Hu Leptin (A-100)[1] Leptin---[1] 265 💬
392Hu MiK-Beta-1----[1] 26 💬
393Hu-G012267----[1] 65 💬
394Huaier granule----[1] 222 💬
395Huaiqihuang Granule----[2] 63, 222 💬
396Huaiqihuang granules----[1] 223 💬
397Huaiqinhuang----[1] 224 💬
398Huang qi gui zhi wu wu granule----[1] 46 💬
399HUC-MSC----[1] 218 💬
400HUC-MSC + DMARDs----[1] 46 💬
401HUC-MSC infusion (BC-U001)----[1] 46 💬
402HUC-MSC suspension----[1] 46 💬
403HUC-MSC-sEV-001 nasal drops----[3] 2, 6, 17 💬
404HUC-MSCs treatment (Double dose)----[1] 49 💬
405HUC-MSCs treatment (high dose)----[1] 49 💬
406HUC-MSCs treatment (low dose)----[1] 49 💬
407HUC-MSCs treatment (medium dose)----[1] 49 💬
408HuCNS-SC----[1] 19 💬
409HuCNS-SC cells----[1] 139 💬
410HuCNS-SC transplant in the lead-in phase----[1] 139 💬
411HuL001----[1] 85 💬
412Hulio----[2] 96, 97 💬
413HuM291----[2] 96, 97 💬
414HuM291)----[1] 97 💬
415Human acylated ghrelin----[1] 78 💬
416HUMAN ALBUMIN AS MACROAGGREGATES----[1] 96 💬
417HUMAN ALBUMIN SOLUTION----[1] 2 💬
418Human allogeneic adipose tissue-derived mesenchymal stem cells expanded----[1] 36 💬
419Human allogeneic induced pluripotent stem cell (iPSC)-derived dopaminergic neural progenitor cell injection----[1] 6 💬
420Human Allogeneic Induced Pluripotent Stem Cells (iPSCs) -Derived Motor Neuron Progenitor Cells (XS228CN)----[1] 2 💬
421Human Allogeneic WJ-MSCs----[1] 36 💬
422Human Amniotic Epithelial Stem Cells----[1] 6 💬
423Human anti TNF-alpha monoclonal----[1] 46 💬
424Human anti TNF-alpha monoclonal antibody----[2] 46, 84 💬
425Human anti-IL 12/23 monoclonal antibody----[1] 84 💬
426Human Anti-IL-12 Antibody----[1] 96 💬
427Human anti-IL-12 IgG1 Mab----[1] 13 💬
428Human anti-IL-12 Mab----[1] 13 💬
429Human anti-IL6 monoclonal antibody----[1] 46 💬
430Human anti-IP10 monoclonal antibody----[2] 96, 97 💬
431Human anti-LINGO-1 monoclonal antibody----[1] 13 💬
432HUMAN ANTI-PROMYOSTATIN MONOCLONAL ANTIBODY----[1] 3 💬
433Human Anti-TNF IgG1 Monoclonal Antibody----[3] 46, 97, 271 💬
434Human anti-TNF-alpha monoclonal antibody----[3] 46, 97, 107 💬
435Human anti-TNFa monoclonal antibody----[1] 271 💬
436Human Anti-TNFalfa----[3] 46, 97, 271 💬
437Human Anti-Transforming Growth Factor Beta-1 Monoclonal Antibody----[1] 51 💬
438Human autologous mesenchymal stem cells----[2] 2, 13 💬
439Human Bone Marrow Mesenchymal Stem Cell (hBMMSC)----[1] 229 💬
440Human dermal fibroblasts cultured on a bioresorbable polyglactin mesh----[1] 36 💬
441Human Dopaminergic Progenitor Cells----[2] 6, 17 💬
442Human Embryonic Stem Cell Derived Retinal Pigment Epithelium (RPE)----[1] 90 💬
443Human fetal-derived Neural Stem Cells (hNSCs)----[1] 13 💬
444HUMAN FIBRINOGEN----[1] 65 💬
445Human Fibrinogen Concentrate----[1] 65 💬
446Human fibroblast-derived dermal substitute, Dermagraft----[1] 36 💬
447Human Glucocerebrosidase (prGCD)----[1] 19 💬
448Human Growth Hormone (1-134)----[1] 78 💬
449Human Heterologous Liver Cells----[1] 251 💬
450Human heterologous liver cells (for infusion)----[1] 251 💬
451Human IgG1 monoclonal antibody against alpha-synuclein----[1] 17 💬
452HUMAN IGG4 ISOTYPE MONOCLONAL (IL2-RG) ANTIBODY----[1] 60 💬
453Human IgG4 monoclonal antibody against CD40----[1] 46 💬
454Human Immunglobulin G (IgG)----[1] 65 💬
455Human Immunoglobulin----[2] 63, 65 💬
456Human immunoglobulin (pH4) for intravenous injection----[1] 63 💬
457HUMAN IMMUNOGLOBULIN G[1] Human immunoglobulin G[1] Globulin, immune 💬 --[4] 14, 50, 63, 65 💬
458Human immunoglobulin intravenous----[1] 63 💬
459Human insulin----[1] 35 💬
460Human interferon beta[1] Human interferon beta[1] Interferon beta 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[2] 13, 26 💬
461Human interferon beta 1a (Rebif)[1] Human interferon beta[1] Interferon beta 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
462Human interferon beta-1a and glatiramer acetate[4] Acetate,
Glatiramer,
Human interferon beta,
Interferon beta-1a		[3] Interferon beta ,
Glatiramer acetate ,
Interferon beta-1a 💬 		[22] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G,
IFNAR1,
IFNAR2 💬 		[44] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Coronavirus disease, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
463Human interleukin-2[1] Human interleukin-2[1] Celmoleukin 💬 [3] IL2RA,
IL2RB,
IL2RG 💬 		[14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬[1] 35 💬
464Human interleukin-6[1] Human interleukin-6---[1] 46 💬
465HUMAN LEUCOCYTE INTERFERON-ALPHA----[1] 13 💬
466HUMAN MESENCHYMAL STEM CELLS----[1] 71 💬
467Human Monoclonal Antibody (CNTO 1275) to Interleukin 12p-40----[1] 96 💬
468Human monoclonal antibody (CNTO 1275) to interleukin-12p40----[1] 13 💬
469Human monoclonal antibody directed against CD20 on B-cells----[1] 46 💬
470Human monoclonal antibody directed against complement 5 protein----[1] 62 💬
471Human N-sulfoglucosamine sulfohydrolase fused to a humanised monoclonal antibody targeting human transferrin receptor----[1] 19 💬
472Human neural stem cell----[1] 6 💬
473Human Neural Stem Cells----[2] 2, 13 💬
474Human normal 10% immunoglobulin for intravenous administration----[1] 14 💬
475Human normal 10% immunoglobulin for intravenous administrationn----[1] 14 💬
476Human normal immunoglobulin----[6] 13, 14, 50, 51, 63, 65 💬
477HUMAN NORMAL IMMUNOGLOBULIN (IV)----[4] 11, 14, 63, 65 💬
478Human normal immunoglobulin (IVIg)----[3] 14, 50, 65 💬
479Human normal immunoglobulin (SCIg)----[1] 14 💬
480Human Normal Immunoglobulin (Subcutaneous - Intramuscular Immunoglobulin)----[1] 65 💬
481Human normal immunoglobulin (subcutaneous)----[1] 65 💬
482HUMAN NORMAL IMMUNOGLOBULIN FOR----[1] 65 💬
483Human normal immunoglobulin for intravenous (IV) administration----[1] 51 💬
484Human normal immunoglobulin for intravenous administration----[3] 14, 51, 65 💬
485HUMAN NORMAL IMMUNOGLOBULIN FOR INTRAVENOUS USE----[2] 63, 65 💬
486Human normal immunoglobulin for intravenous use (IVIG)----[1] 65 💬
487HUMAN NORMAL IMMUNOGLOBULIN FOR INTRVENOUS USE----[1] 63 💬
488Human normal immunoglobulin for subcutaneous administration----[2] 51, 65 💬
489Human Normal Immunoglobulin for Subcutaneous Administration (IGSC)----[1] 65 💬
490Human normal immunoglobulin G (IgG > 98% purity)----[3] 14, 63, 65 💬
491Human normal immunoglobulin G (IgG)----[1] 11 💬
492Human normal immunoglogulin (IVIg)----[1] 50 💬
493Human papillomavirus vaccination (Gardasil)----[1] 49 💬
494Human Papillomavirus Vaccine----[1] 97 💬
495Human Placenta-Derived Cells PDA001 Intravenous Infusion----[1] 96 💬
496Human Placental Derived Stem Cell----[4] 19, 20, 60, 284 💬
497HUMAN PLASMA FOR FRACTIONATION----[1] 96 💬
498Human primary Retinal Pigment Epithelial (HuRPE) cells----[1] 90 💬
499Human recombinant growth hormone----[2] 13, 299 💬
500Human Recombinant IgG1, lambda----[1] 46 💬
501Human recombinant leptin (metreleptin)[2] Leptin,
Metreleptin		[1] Metreleptin 💬 [1] LEPR 💬 [7] AMPK signaling pathway, Adipocytokine signaling pathway, Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease 💬[1] 265 💬
502Human recombinant parathyroid Hormone[1] Parathyroid hormone[1] Parathyroid hormone 💬 [2] PTH1R,
PTH2R 💬 		[4] Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬[1] 235 💬
503Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein[1] Alkaline Phosphatase---[1] 172 💬
504Human retinal progenitor cells----[1] 90 💬
505Human Retinal Progenitor Cells Drug Product----[1] 90 💬
506Human Secretin----[1] 298 💬
507Human soluble recombinant Fc-gamma receptor IIB----[1] 66 💬
508Human Stem Cells----[1] 6 💬
509Human TH-SC01 cell injection----[1] 96 💬
510Human Transthyretin Antisense Oligonucleotide----[1] 28 💬
511Human Umbilical Cord Blood-derived Mesenchymal Stem Cells----[1] 36 💬
512Human umbilical cord derived MSC transplantation for SLE----[1] 49 💬
513Human umbilical cord mesenchymal stem cell injection----[1] 85 💬
514Human Umbilical Cord Mesenchymal Stem Cells[1] Human Umbilical Cord Mesenchymal Stem Cells---[5] 13, 96, 97, 113, 271 💬
515Human Umbilical Cord Mesenchymal Stem Cells (UC-MSC)[1] Human Umbilical Cord Mesenchymal Stem Cells---[1] 113 💬
516Human umbilical cord-derived MSCs----[1] 271 💬
517Human Wharton's jelly-derived mesenchymal stem cells----[1] 10 💬
518Human-derived stromal cells----[1] 6 💬
519Humanised anti-CD 20 antibody----[1] 46 💬
520Humanised anti-CD4 IgG1 monoclonal----[1] 46 💬
521Humanised IgG1 monoclonal antibody against blood dendritic cell antigen 2----[1] 49 💬
522Humanised IgG1 monoclonal antibody against human eotaxin-2----[1] 94 💬
523Humanised IgG1 monoclonal antibody against misfolded transthyretin----[1] 28 💬
524Humanised IgG1K monoclonal antibody against interferon beta----[1] 50 💬
525Humanised IgG1k monoclonal antibody against KIT----[1] 98 💬
526Humanised VHH-type bispecific antibody against Complement component 5 and serum albumin----[1] 11 💬
527Humanised VHH-type bispecific antibody that binds to Complement component 5 and serum albumin----[1] 11 💬
528Humanized anti-alpha v beta 6 mAb----[1] 85 💬
529Humanized anti-Factor Bb monoclonal antibody----[1] 62 💬
530Humanized IgG1 kappa antiamyloid----[1] 28 💬
531Humanized IgG1, kappa anti-serum amyloid A and anti-AL amyloid antibody----[1] 28 💬
532Humanized immunoglobulin gamma 1 (IgG1) kappa monoclonal antibody----[1] 46 💬
533Humanized recombinant IgG4 monoclonal antibody against CD-127----[1] 97 💬
534Humanized TNFa monoclonal antibody----[1] 46 💬
535Humatrope----[1] 274 💬
536Humatrope 6 mg/12 mg/24 mg injektiokuiva-aine ja liuotin, liuosta varten----[1] 193 💬
537HuMax-CD20[1] Ofatumumab[1] Ofatumumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[2] 13, 46 💬
538HUMAX-CD38----[2] 28, 63 💬
539HuMax-CD38, 3003-005----[1] 28 💬
540HuMax-CD4----[1] 46 💬
541HUMIRA----[9] 46, 56, 84, 96, 97, 107, 160, 269, 271 💬
542Humira (adalimumab original)[1] Adalimumab[1] Adalimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[2] 96, 97 💬
543HUMIRA (ADALIMUMAB)[1] Adalimumab[1] Adalimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[2] 46, 96 💬
544Humira (adalimumab) 40 mg in 0.4 ml s.c. injection[1] Adalimumab[1] Adalimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
545Humira (adalimumab) 40 mg s.c. injection[1] Adalimumab[1] Adalimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
546Humira (adalimumab) 40mg in 0.4 ml s.c. injection[1] Adalimumab[1] Adalimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
547Humira (adalimumab) 40mg in 0.4ml s.c.injection[1] Adalimumab[1] Adalimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
548HUMIRA - 40 MG SOLUZIONE INIETTABILE USO SOTTOCUTANEO 1 SIRINGA PRERIEMPITA 0.8 ML + 1 TAMPONE IMBEVUTO DI ALCOL IN UN BLISTER----[2] 56, 97 💬
549HUMIRA - 40 MG SOLUZIONE INIETTABILE USO SOTTOCUTANEO 2 SIRINGHE PRERIEMPITE 0.8 ML + 2 TAMPONI IMBEVUTI DI ALCOL IN 1 BLISTER----[1] 46 💬
550HUMIRA - 40MG/0.8ML SOLUZ. INIETTABILE- USO SOTTOCUTANEO-FLACONCINO(VETRO) 0.8ML 2 ASTUCCI:1 FLACONCINO+1SIRINGA+1AGO+1ADATT.STERILE-2TAMPONI IMBEVUTI ALCOOL----[2] 46, 96 💬
551Humira 20 mg solution for injection in pre-filled syringe----[1] 96 💬
552Humira 20 mg solution for injection in pre-filled syringe (20 mg/0.2mL)----[1] 97 💬
553Humira 40 mg injekcní roztok v predplnené injekcní stríkacce----[1] 96 💬
554Humira 40 mg injeksjonsvæske, oppløsning, i ferdigfylt sprøyte----[1] 46 💬
555HUMIRA 40 mg solución inyectable en jeringa precargada----[2] 46, 96 💬
556Humira 40 mg solution for injection in pre-filled pen----[1] 96 💬
557Humira 40 mg solution for injection in pre-filled syringe----[3] 46, 96, 97 💬
558Humira 40 mg solution for injection in pre-filled syringe (40 mg/0.4 mL)----[1] 97 💬
559Humira 40 mg solution for injection in pre-filled syringes----[1] 97 💬
560Humira 40 mg/0.8 ml solution for injection----[4] 46, 96, 97, 271 💬
561Humira 40 mg/0.8 ml solution for injection for paediatric use----[1] 97 💬
562Humira 40mg Injektionslösung----[1] 46 💬
563HUMIRA 40Mg Solution for Injection----[2] 96, 97 💬
564Humira 40mg solution for injection in pre-filled syringe----[1] 46 💬
565Humira 40mg solution for injection in pre-filled syringe (adalimumab)[1] Adalimumab[1] Adalimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
566Humira 40mg, solution injectable en stylo prérempli----[1] 56 💬
567Humira 40mg/0.4ml pre-filled syringe----[2] 96, 97 💬
568Humira 40mg/0.8 ml solution for injection for paediatric use----[1] 46 💬
569Humira 40mg/0.8ml solution for injection for paediatric use----[1] 96 💬
570Humira 40mg/0.8ml solution for injection in pre-filled syringe----[1] 46 💬
571Humira 80 mg solution for injection in pre-filled syringe (80 mg/0.8 mL)----[1] 97 💬
572Humira pre-filled PEN----[1] 96 💬
573Humira SC----[1] 46 💬
574HUMIRA ®----[2] 96, 97 💬
575Humira ® (Adalimumab) 40mg/0.8mL Pre-filled Syringe[1] Adalimumab[1] Adalimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
576HUMIRA*SC 2SIR+F 40MG 0,8ML+2T----[2] 46, 96 💬
577Humira, 40 mg solution for injection in pre-filled syringe----[1] 46 💬
578Humira, Hulio, Amgevita, Hyrimoz, Idacio, Imraldi----[1] 46 💬
579Humira®----[5] 46, 96, 97, 107, 271 💬
580Humira® (adalimumab)[1] Adalimumab[1] Adalimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
581Humira® 40 mg Injektionslösung in Fertigspritze----[1] 46 💬
582Humira® 40 mg solution for injection in pre-filled syringe----[1] 46 💬
583Humira® 40 mg/ 0.8 ml solution for injection in pre-filled syringe----[1] 46 💬
584Hunterase----[1] 19 💬
585Huolingshengji Granules----[1] 2 💬
586Huoluo Pills----[1] 46 💬
587HW201877 capsules----[1] 97 💬
588HW241045 Formulation A----[1] 85 💬
589HW241045 Formulation B----[1] 85 💬
590Hyaluronic acid[1] Hyaluronic acid[2] Hyaluronate sodium ,
Hyaluronic acid 💬 		--[5] 46, 53, 70, 226, 231 💬
591Hyaluronic Acid (HA)[1] Hyaluronic acid[2] Hyaluronate sodium ,
Hyaluronic acid 💬 		--[1] 226 💬
592Hyaluronic Acid and Chondroitin Sulfate[2] Chondroitin sulfate,
Hyaluronic acid		[3] Chondroitin sulfate A ,
Hyaluronate sodium ,
Hyaluronic acid 💬 		--[1] 226 💬
593Hyaluronic Acid Inhalation Solution[1] Hyaluronic acid[2] Hyaluronate sodium ,
Hyaluronic acid 💬 		--[1] 231 💬
594Hyaluronic acid/chondroitin sulfate[2] Chondroitin sulfate,
Hyaluronic acid		[3] Chondroitin sulfate A ,
Hyaluronate sodium ,
Hyaluronic acid 💬 		--[1] 226 💬
595Hyaluronidase[1] Hyaluronidase[3] Hyaluronidase ,
Hyaluronidase ,
Hyaluronidase 💬 		--[7] 13, 14, 28, 51, 60, 65, 331 💬
596Hyaluronidase injected intradermally[1] Hyaluronidase[3] Hyaluronidase ,
Hyaluronidase ,
Hyaluronidase 💬 		--[1] 51 💬
597Hydralazine[1] Hydralazine[3] Hydralazine hydrochloride ,
Hydralazine polistirex ,
Hydralazine 💬 		[1] AOC3 💬 [4] Glycine, serine and threonine metabolism, Phenylalanine metabolism, Tyrosine metabolism, beta-Alanine metabolism 💬[1] 67 💬
598Hydrochloorthiazide----[1] 225 💬
599HYDROCHLOROTHIAZIDE[1] Hydrochlorothiazide[1] Hydrochlorothiazide 💬 [1] SLC12A3 💬 [1] Parathyroid hormone synthesis, secretion and action 💬[5] 13, 67, 222, 225, 235 💬
600Hydrochlorothiazide 25 mg[1] Hydrochlorothiazide[1] Hydrochlorothiazide 💬 [1] SLC12A3 💬 [1] Parathyroid hormone synthesis, secretion and action 💬[1] 67 💬
601Hydrochlorothiazide/amiloride[2] Amiloride,
Hydrochlorothiazide		[3] Hydrochlorothiazide ,
Amiloride hydrochloride ,
Amiloride 💬 		[4] SCNN1A,
SCNN1B,
SCNN1G,
SLC12A3 💬 		[3] Aldosterone-regulated sodium reabsorption, Parathyroid hormone synthesis, secretion and action, Taste transduction 💬[1] 225 💬
602Hydrocortison 100 mg (Pfizer®) in 2 ml solvent----[1] 83 💬
603Hydrocortisone[1] Hydrocortisone[1] Hydrocortisone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[10] 6, 41, 46, 53, 75, 78, 81, 83, 97, 299 💬
604Hydrocortisone (Solucortef)[1] Hydrocortisone[1] Hydrocortisone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 81 💬
605HYDROCORTISONE - hydrocortisone tablet[1] Hydrocortisone[1] Hydrocortisone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 81 💬
606Hydrocortisone 100mg/ml[1] Hydrocortisone[1] Hydrocortisone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 83 💬
607Hydrocortisone 10mg[1] Hydrocortisone[1] Hydrocortisone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
608Hydrocortisone 10mg Tablet[1] Hydrocortisone[1] Hydrocortisone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 81 💬
609Hydrocortisone 10mg Tablets[1] Hydrocortisone[1] Hydrocortisone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 81 💬
610Hydrocortisone 20mg Tablets[1] Hydrocortisone[1] Hydrocortisone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 81 💬
611HYDROCORTISONE ACETATE[3] Acetate,
Hydrocortisone,
Hydrocortisone acetate		[2] Hydrocortisone ,
Hydrocortisone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
612Hydrocortisone cream[1] Hydrocortisone[1] Hydrocortisone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 6 💬
613Hydrocortisone cream 1%[1] Hydrocortisone[1] Hydrocortisone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 6 💬
614Hydrocortisone cream 10mg/g FNA Fagron[1] Hydrocortisone[1] Hydrocortisone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 6 💬
615HYDROCORTISONE HYDROGEN SUCCINATE[2] Hydrocortisone,
Hydrogen		[1] Hydrocortisone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 83 💬
616HYDROCORTISONE MICRONIZED[1] Hydrocortisone[1] Hydrocortisone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 81 💬
617Hydrocortisone Modified Release Capsules[1] Hydrocortisone[1] Hydrocortisone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 81 💬
618HYDROCORTISONE ROUSSEL[1] Hydrocortisone[1] Hydrocortisone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 83 💬
619Hydrocortisone sodium acetate[3] Acetate,
Hydrocortisone,
Sodium acetate		[2] Hydrocortisone ,
Sodium acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 81 💬
620HYDROCORTISONE SODIUM PHOSPHATE[2] Hydrocortisone,
Hydrocortisone phosphate		[2] Hydrocortisone ,
Hydrocortisone sodium phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[3] 53, 81, 83 💬
621HYDROCORTISONE SODIUM SUCCINATE[3] Hydrocortisone,
Hydrocortisone succinate,
Succinic acid		[3] Hydrocortisone ,
Hydrocortisone sodium succinate ,
Hydrocortisone succinate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[3] 81, 83, 97 💬
622Hydrocortisone tablet 2.5 mg[1] Hydrocortisone[1] Hydrocortisone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 81 💬
623Hydrocortisone TAKEDA, tabletter[1] Hydrocortisone[1] Hydrocortisone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 78 💬
624Hydrocortisone withdrawal[1] Hydrocortisone[1] Hydrocortisone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 81 💬
625HYDROCORTISONE- hydrocortisone tablet[1] Hydrocortisone[1] Hydrocortisone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 81 💬
626Hydrocortisonum[1] Hydrocortisone[1] Hydrocortisone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 83 💬
627Hydrocortone----[1] 78 💬
628Hydrogen[1] Hydrogen---[8] 5, 6, 13, 17, 83, 97, 226, 238 💬
629Hydrogen peroxide[2] Hydrogen,
Hydrogen peroxide		[1] Hydrogen peroxide 💬 --[1] 13 💬
630Hydrokortison----[1] 41 💬
631Hydrokortison APL kapsel 2,5 mg----[1] 83 💬
632Hydrokortison Glostrup 5 mg----[1] 78 💬
633Hydrokortison orion----[1] 41 💬
634Hydrolyzed guar gum[1] Guar gum[1] Guar gum 💬 --[1] 6 💬
635Hydromorphone[1] Hydromorphone[2] Hydromorphone hydrochloride ,
Hydromorphone 💬 		[1] OPRM1 💬 [5] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[1] 70 💬
636Hydroxocobalamin[1] Hydroxocobalamin[2] Hydroxocobalamin ,
Hydroxocobalamin acetate 💬 		--[3] 97, 246, 337 💬
637Hydroxocobalamin Chloride Injection[1] Hydroxocobalamin[2] Hydroxocobalamin ,
Hydroxocobalamin acetate 💬 		--[2] 246, 337 💬
638Hydroxocobalamin with Butyrate[1] Hydroxocobalamin[2] Hydroxocobalamin ,
Hydroxocobalamin acetate 💬 		--[1] 97 💬
639Hydroxychloroquine[1] Hydroxychloroquine[2] Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--[29] 6, 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 223, 224, 234, 254, 271, 298, 299 💬
640Hydroxychloroquine (HCQ)[1] Hydroxychloroquine[2] Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--[2] 6, 53 💬
641Hydroxychloroquine (Z0188)[1] Hydroxychloroquine[2] Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--[1] 49 💬
642Hydroxychloroquine + low-dose prednisone[2] Hydroxychloroquine,
Prednisone		[3] Prednisone ,
Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 84 💬
643Hydroxychloroquine + Prednisone[2] Hydroxychloroquine,
Prednisone		[3] Prednisone ,
Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 84 💬
644Hydroxychloroquine 400mg/d[1] Hydroxychloroquine[2] Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--[1] 53 💬
645Hydroxychloroquine and SoC[1] Hydroxychloroquine[2] Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--[2] 66, 223 💬
646Hydroxychloroquine higher dose[1] Hydroxychloroquine[2] Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--[1] 90 💬
647Hydroxychloroquine lower dose[1] Hydroxychloroquine[2] Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--[1] 90 💬
648Hydroxychloroquine or Chloroquine[2] Chloroquine,
Hydroxychloroquine		[6] Hydroxychloroquine sulfate ,
Chloroquine phosphate ,
Chloroquine ,
Chloroquine hydrochloride ,
Chloroquine sulfate ,
Hydroxychloroquine 💬 		--[1] 49 💬
649Hydroxychloroquine Oral Tablet[1] Hydroxychloroquine[2] Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--[2] 63, 66 💬
650Hydroxychloroquine Pill[1] Hydroxychloroquine[2] Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--[1] 13 💬
651Hydroxychloroquine reduced[1] Hydroxychloroquine[2] Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--[1] 49 💬
652Hydroxychloroquine sulfate[1] Hydroxychloroquine[2] Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--[5] 13, 46, 48, 53, 66 💬
653Hydroxychloroquine Sulfate 100 milligram (mg) Tab[1] Hydroxychloroquine[2] Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--[1] 218 💬
654Hydroxychloroquine Sulfate Tablets[1] Hydroxychloroquine[2] Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--[2] 48, 53 💬
655HYDROXYCHLOROQUINE SULPHATE[1] Hydroxychloroquine[2] Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--[1] 96 💬
656Hydroxycholoquine----[1] 46 💬
657Hydroxycloroquina----[1] 46 💬
658Hydroxyethyl Starch[1] Hydroxyethyl Starch[1] Hetastarch 💬 --[1] 97 💬
659Hydroxypropyl-beta-cyclodextrin----[1] 19 💬
660Hydroxypropyl-ß-cyclodextrin----[1] 19 💬
661Hydroxytyrosol[1] Hydroxytyrosol---[1] 13 💬
662Hydroxyurea[1] Hydroxyurea[1] Hydroxyurea 💬 [1] RRM2 💬 [5] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway 💬[10] 3, 13, 19, 20, 46, 65, 85, 86, 107, 284 💬
663Hylase----[1] 46 💬
664Hymecromone[1] Hymecromone[1] Hymecromone 💬 --[2] 85, 94 💬
665HYNR-CS inj----[1] 2 💬
666HYNRCS-Allo inj----[1] 2 💬
667Hyperbaric Oxygen[1] Oxygen[1] Oxygen 💬 --[3] 46, 97, 269 💬
668Hyperbaric Oxygen Therapy[1] Oxygen[1] Oxygen 💬 --[2] 71, 90 💬
669Hyperbaric Oxygen Therapy (HBOT)[1] Oxygen[1] Oxygen 💬 --[1] 226 💬
670Hyperbaric oxygen treatment (HBOT)[1] Oxygen[1] Oxygen 💬 --[6] 13, 15, 36, 96, 97, 269 💬
671Hypercapnia Challenge using the device (RespirAct)----[1] 140 💬
672Hypercortisolism----[1] 75 💬
673Hyperglycemic clamp----[1] 299 💬
674Hyperglycemic Clamp with concurrent GIP infusion----[1] 299 💬
675Hyperglycemic clamp with concurrent GLP-1 infusion----[1] 299 💬
676Hyperimmune caprine serum----[1] 51 💬
677Hyperimmune caprine serum against HIV lysate----[1] 13 💬
678Hyperinsulinemic euglycemic clamp----[3] 316, 317, 344 💬
679Hyperium[1] Rilmenidine[1] Rilmenidine 💬 [3] ADRA2A,
ADRA2B,
ADRA2C 💬 		[4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 8 💬
680Hyperoxia----[2] 51, 85 💬
681Hyperpolarized 129 Xenon Gas Comparing Idiopathic Pulmonary Fibrosis (IPF) Treatment[1] Xenon[2] Xenon ,
Xenon Xe 133 💬 		--[1] 85 💬
682Hyperpolarized 129 Xenon Gas Comparing Progressive Pulmonary Fibrosis Treatment[1] Xenon[2] Xenon ,
Xenon Xe 133 💬 		--[1] 85 💬
683Hyperpolarized 129-Xenon gas[1] Xenon[2] Xenon ,
Xenon Xe 133 💬 		--[1] 85 💬
684Hyperpolarized 129Xe----[1] 86 💬
685Hyperpolarized 13C-pyruvate----[1] 86 💬
686Hyperpolarized [1-13C]pyruvate[1] Pyruvic acid---[2] 2, 67 💬
687Hyperpolarized Helium-3[1] Helium[1] Helium 💬 --[1] 299 💬
688Hyperpolarized Helium-3 MRI[1] Helium[1] Helium 💬 --[1] 228 💬
689Hyperpolarized Helium-3 MRI of the chest[1] Helium[1] Helium 💬 --[1] 299 💬
690Hyperpolarized Xe129----[5] 51, 85, 86, 88, 299 💬
691Hyperpolarized Xenon[1] Xenon[2] Xenon ,
Xenon Xe 133 💬 		--[1] 299 💬
692Hyperpolarized Xenon 129[1] Xenon[2] Xenon ,
Xenon Xe 133 💬 		--[1] 299 💬
693Hyperpolarized Xenon gas[1] Xenon[2] Xenon ,
Xenon Xe 133 💬 		--[1] 299 💬
694Hyperpolarized xenon-129[1] Xenon[2] Xenon ,
Xenon Xe 133 💬 		--[1] 299 💬
695Hypersaline----[1] 294 💬
696Hypersialylated immunoglobulin----[1] 63 💬
697Hypertonic bicarbonate----[1] 299 💬
698Hypertonic saline----[3] 222, 299, 340 💬
699Hypertonic saline (7 %) and isotonic saline (0.9%)----[1] 299 💬
700Hypertonic saline (7%)----[1] 299 💬
701Hypertonic saline 6% -----[1] 299 💬
702Hypertonic Saline 7%----[1] 299 💬
703Hypertonic saline solution----[1] 299 💬
704Hypoestoxide----[1] 6 💬
705HypotonicTreprostinil Solution----[1] 86 💬
706Hypoxic Gas Mixture----[1] 6 💬
707HYQVIA----[2] 14, 65 💬
708HYQVIA - 100 MG/ML - SOLUZIONE PER INFUSIONE - USO SOTTOCUTANEO - FLACONCINO (VETRO) 300 ML E FLACONCINO (VETRO) 15 ML - 1 FLACONCINO + 1 FLACONCINO----[1] 14 💬
709HyQvia 100 mg/ml solution for infusion for subcutaneous use----[2] 14, 65 💬
710Hyrimoz----[1] 271 💬
711HZN-1116----[1] 53 💬
712HZN-7734, VIB7734----[1] 49 💬
713HZN-7734, VIB7734, MEDI7734----[1] 49 💬
714HZN-825----[2] 51, 85 💬
715HZN-825 BID----[1] 51 💬
716HZN-825 QD----[1] 51 💬
717HZT-501[1] HZT-501---[1] 46 💬